← Eichor
Condition: Pd L1 Related Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pd L1 Related Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Montreal Immune-Related Adverse Events (MIRAE) Study
Phase N/A · 1 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT05139706Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Diseas
Phase N/A · 1 location(s) · Hospital Universitario Araba · NCT07249060Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients
Phase N/A · 2 location(s) · Tianjin Medical University · NCT07618936Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma ,
Phase N/A · 1 location(s) · Daniel Keizman · NCT07485114Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
Phase N/A · 1 location(s) · Qinghai Red Cross Hospital · NCT06915389IMMUNO-FIT Observational Study
Phase N/A · 1 location(s) · University Hospital Southampton NHS Foundation Trust · NCT07354971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.